Glow
GLOW blend · GHK-Cu + BPC-157 + TB-500 · skin + tissue repair blend
ANECDOTAL · THREE-COMPONENT REGENERATIVE BLEND (MATRIKINE + CYTOPROTECTIVE + ACTIN-REGULATOR)
Mechanism of action
Layered remodelling: GHK-Cu's copper-peptide matrikine signal upregulates collagen and elastin transcription and engages roughly 4,000 wound-healing genes; BPC-157 drives angiogenesis via VEGFR2 and stabilises epithelial / connective-tissue repair; TB-500 sequesters G-actin to enable cell migration and amplifies stem-cell mobilisation. Together: matrix synthesis + vessel-bed repair + cell-migration substrate.
Researched effects
Skin regeneration; injury and wound recovery; collagen and elastin synthesis support; dermal remodelling; commonly the entry-point recovery blend before stepping up to Klow (which adds an anti-inflammatory arm)
Dosing reported in literature
Typical SC protocols deliver ~250-500 mcg per component daily for 4-6 week loading cycles. Confirm per-component dose from the vial total before reconstitution
Known concerns
No human trials of the combined formulation; TB-500 WADA-banned with theoretical pro-proliferative concerns; chronic GHK-Cu raises copper-accumulation considerations at high doses; injection-site reactions
No references match — clear filters.
Curated sources on file
4- 1.
- 2.
- 3.
-
4.
Note: Glow is a vendor-marketed three-peptide blend with no published human trials of the combination; cited papers describe each component separately.